Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Dyslipidemia

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 24 articles:
HTML format



Single Articles


    July 2021
  1. BJORNSTAD P, Drews KL, Caprio S, Gubitosi-Klug R, et al
    Long-Term Complications in Youth-Onset Type 2 Diabetes.
    N Engl J Med. 2021;385:416-426.
    PubMed     Abstract available


    March 2021
  2. GIBBONS GH, Seidman CE, Topol EJ
    Conquering Atherosclerotic Cardiovascular Disease - 50 Years of Progress.
    N Engl J Med. 2021;384:785-788.
    PubMed    


    February 2021
  3. RAAL FJ, Gaudet D, Gusarova V
    Evinacumab for Homozygous Familial Hypercholesterolemia. Reply.
    N Engl J Med. 2021;384:e17.
    PubMed    


  4. XU HG
    Evinacumab for Homozygous Familial Hypercholesterolemia.
    N Engl J Med. 2021;384:e17.
    PubMed    


  5. LUO F, Das A, Fang Z
    Evinacumab for Homozygous Familial Hypercholesterolemia.
    N Engl J Med. 2021;384:e17.
    PubMed    


  6. AGIRBASLI M
    Evinacumab for Homozygous Familial Hypercholesterolemia.
    N Engl J Med. 2021;384:e17.
    PubMed    


    January 2021
  7. GAUDET D, Ruzza A, Santos RD
    Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia. Reply.
    N Engl J Med. 2021;384:84-85.
    PubMed    


  8. SINGH A, Mittal S, Kazimuddin M
    Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia.
    N Engl J Med. 2021;384:84.
    PubMed    


    December 2020
  9. MARTIN SS
    Factoring in ANGPTL3 When LDL Is Refractory.
    N Engl J Med. 2020;383:2385-2386.
    PubMed    


    November 2020
  10. SHAW AT, Bauer TM, de Marinis F, Felip E, et al
    First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer.
    N Engl J Med. 2020;383:2018-2029.
    PubMed     Abstract available


  11. ROSENSON RS, Burgess LJ, Ebenbichler CF, Baum SJ, et al
    Evinacumab in Patients with Refractory Hypercholesterolemia.
    N Engl J Med. 2020 Nov 15. doi: 10.1056/NEJMoa2031049.
    PubMed     Abstract available


    October 2020
  12. DE FERRANTI SD
    Evolocumab in Children with Heterozygous Familial Hypercholesterolemia.
    N Engl J Med. 2020;383:1385-1386.
    PubMed    


    August 2020
  13. SANTOS RD, Ruzza A, Hovingh GK, Wiegman A, et al
    Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia.
    N Engl J Med. 2020 Aug 29. doi: 10.1056/NEJMoa2019910.
    PubMed     Abstract available


  14. KERSTEN S
    Bypassing the LDL Receptor in Familial Hypercholesterolemia.
    N Engl J Med. 2020;383:775-776.
    PubMed    


  15. RAAL FJ, Rosenson RS, Reeskamp LF, Hovingh GK, et al
    Evinacumab for Homozygous Familial Hypercholesterolemia.
    N Engl J Med. 2020;383:711-720.
    PubMed     Abstract available


    April 2020
  16. RAY KK, Wright RS, Kallend D, Koenig W, et al
    Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.
    N Engl J Med. 2020;382:1507-1519.
    PubMed     Abstract available


    January 2020
  17. LUIRINK IK, Kusters DM, Hutten BA
    Statins for Familial Hypercholesterolemia from Childhood. Reply.
    N Engl J Med. 2020;382:488-489.
    PubMed    


  18. MURATA Y, Kami M
    Statins for Familial Hypercholesterolemia from Childhood.
    N Engl J Med. 2020;382:488.
    PubMed    


  19. BIJL D, Hama R
    Statins for Familial Hypercholesterolemia from Childhood.
    N Engl J Med. 2020;382:487-488.
    PubMed    


    December 2019
  20. WITZTUM JL, Geary RS, O'Dea L
    Volanesorsen, Familial Chylomicronemia Syndrome, and Thrombocytopenia. Reply.
    N Engl J Med. 2019;381:2584.
    PubMed    


  21. KHETARPAL SA, Wang M, Khera AV
    Volanesorsen, Familial Chylomicronemia Syndrome, and Thrombocytopenia.
    N Engl J Med. 2019;381:2582-2584.
    PubMed    


    October 2019
  22. MICHOS ED, McEvoy JW, Blumenthal RS
    Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease.
    N Engl J Med. 2019;381:1557-1567.
    PubMed    


  23. LUIRINK IK, Wiegman A, Kusters DM, Hof MH, et al
    20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia.
    N Engl J Med. 2019;381:1547-1556.
    PubMed     Abstract available


    September 2019
  24. MUNOZ D, Uzoije P, Reynolds C, Miller R, et al
    Polypill for Cardiovascular Disease Prevention in an Underserved Population.
    N Engl J Med. 2019;381:1114-1123.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: